Recent Posts

December 4, 2022 2022 Q4 | December 2022

Engaging in an AIM-Bio future path ideation brainstorming session at BTEC on Nov. 10 are, left to right, Andreas Visbech Madsen, PhD student in DTU Bioengineering; Dr. Lasse Ebdrup Pedersen, senior researcher in DTU Bioengineering; Dr. Nathan Crook, assistant professor in NC State’s Department of Chemical and Biomolecular Engineering; and Dr. Carol Hall, Camille Dreyfus Distinguished University Professor in NC State’s Department of Chemical and Biomolecular Engineering.

AIM-Bio Symposium participants engage in Future Path Ideation sessions

By jwhitle The AIM-Bio Biopharmaceutical Manufacturing Symposium held Nov. 9–11, 2022, provided an excellent opportunity for members of the AIM-Bio project team to begin brainstorming the future...

December 4, 2022 2022 Q4 | December 2022

Ryan Kilgore, PhD student (far right), discusses AIM-Bio research in the Engineering Building 1 labs at NC State University.

AIM-Bio Symposium open house showcases NC State facilities and expertise

By jwhitle The third annual Accelerated Innovation in Manufacturing Biologics (AIM-Bio) Symposium, which took place Nov. 9–11, 2022, was the first symposium to be held in person....

December 4, 2022 2022 Q4 | December 2022

Laura Niklason, PhD, MD, delivered a keynote talk, “Bioengineering Human Tissue Replacements from Scratch,” on Nov. 9, 2022, the opening day of the AIM-Bio Biopharmaceutical Manufacturing Symposium, which was held at NC State. Dr. Niklason is the founder, president, and chief executive officer of Humacyte, located in Durham.

Keynote speakers and interviews kick off Biopharmaceutical Manufacturing Symposium

By jwhitle The third annual AIM-Bio Biopharmaceutical Manufacturing Symposium, which was held at NC State University Nov. 9–11, 2022, was attended by over 80 people. Participating were...